These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22654506)

  • 21. Treating allergic rhinitis by sublingual immunotherapy: a review.
    Incorvaia C; Di Rienzo A; Celani C; Makrì E; Frati F
    Ann Ist Super Sanita; 2012; 48(2):172-6. PubMed ID: 22751560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mite immunotherapy.
    Fernández-Caldas E; Iraola V; Boquete M; Nieto A; Casanovas M
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):413-9. PubMed ID: 16899204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergen-specific immunotherapy for allergic rhinitis in the elderly: is it never too late?
    Milani M
    Immunotherapy; 2013 Jul; 5(7):699-702. PubMed ID: 23829621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis.
    Jordakieva G; Kundi M; Lemell P; Zieglmayer R; Zieglmayer P; Godnic-Cvar J; Jensen-Jarolim E
    Sci Rep; 2017 May; 7(1):2555. PubMed ID: 28566688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allergen immunotherapy in asthma: current evidence.
    Novakova P; Tiotiu A; Baiardini I; Krusheva B; Chong-Neto H; Novakova S
    J Asthma; 2021 Feb; 58(2):223-230. PubMed ID: 31638840
    [No Abstract]   [Full Text] [Related]  

  • 28. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases.
    Ferrando M; Bagnasco D; Passa-Lacqua G; Puggioni F; Varricchi G; Canonica GW
    Curr Pharm Biotechnol; 2017; 18(5):378-383. PubMed ID: 28413977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of sublingual immunotherapy in Asian children.
    Park IH; Hong SM; Lee HM
    Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.
    O'Hehir RE; Gardner LM; de Leon MP; Hales BJ; Biondo M; Douglass JA; Rolland JM; Sandrini A
    Am J Respir Crit Care Med; 2009 Nov; 180(10):936-47. PubMed ID: 19696440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
    Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
    Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of house dust mite allergy.
    Yang L; Zhu R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2390-2396. PubMed ID: 28853977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral.
    Frati F; Scurati S; Puccinelli P; Justicia JL; Adamec T; Sieber HJ; Ras L; David M; Marcucci F; Incorvaia C
    Expert Opin Biol Ther; 2009 Sep; 9(9):1207-15. PubMed ID: 19601728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy.
    Penagos M; Durham SR
    Allergy Asthma Proc; 2022 Jul; 43(4):292-298. PubMed ID: 35818157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.
    de Bot CM; Moed H; Berger MY; Röder E; Hop WC; de Groot H; de Jongste JC; van Wijk RG; Bindels PJ; van der Wouden JC
    Pediatr Allergy Immunol; 2012 Mar; 23(2):150-8. PubMed ID: 22017365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a sublingual allergy vaccine for grass pollinosis.
    Frati F; Scurati S; Puccinelli P; David M; Hilaire C; Capecce M; Marcucci F; Incorvaia C
    Drug Des Devel Ther; 2010 Jul; 4():99-105. PubMed ID: 20689696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [DIFFERENCE BETWEEN STANDARDIZED MITE ANTIGEN AND HOUSE DUST EXTRACT IN RUSH SUBCUTANEOUS IMMUNOTHERAPY FOR CHILDREN].
    Tanaka Y; Okafuji I; Omae S; Mitobe Y; Doi K; Tsuruta S
    Arerugi; 2019; 68(6):681-690. PubMed ID: 31308334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.